MTAPの消去は,がん細胞におけるPRMT5アルギニンメチルトランスフェラーゼへの依存性を高めます
Gregory V Kryukov1, Frederick H Wilson1, Jason R Ruth1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
まとめ
メチルチオアデノシンリン酸化酵素 (MTAP) の損失は,PRMT5の抑制に対する癌の脆弱性を生み出します. この発見は,MTAPが削除された癌の新たな治療目標を提供します.
科学分野:
- 腫瘍学
- 分子生物学
- ガンゲノミクス
背景:
- がん依存性は治療戦略と薬物の標的の特定を導くことができます.
- メチルチオアデノシンリン酸化酵素 (MTAP) は,CDKN2A腫瘍抑制遺伝子の近くにあるため,がんではしばしば失われます.
研究 の 目的:
- 癌におけるMTAPの機能的影響を調査する.
- MTAPの削除に関連した潜在的な治療上の脆弱性を特定する.
主な方法:
- ガン細胞のゲノム解析
- 癌細胞依存性の機能的特徴
- 細胞内メチルチオアデノシン (MTA) 濃度測定
- PRMT5の酵素活性の測定
- MTAとPRMT5阻害剤に対する細胞活性の評価
主要な成果:
- MTAPの喪失は,タンパク質アルギニンメチルトランスファーゼ5 (PRMT5) とWDR77への選択的依存につながります.
- MTAPが削除された細胞は,PRMT5を阻害するメチルチオアデノシン (MTA) を蓄積する.
- MTAおよびPRMT5阻害剤は,MTAPゼロの癌細胞の生存能力を優先的に低下させる.
結論:
- PRMT5は,MTAPの欠失があるがんにおける潜在的な治療的脆弱性です.
- MTAPの損失の一般的なゲノム変異は,PRMT5への標的依存性を生み出します.
関連する概念動画
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression
1.6K
No description available
1.6K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway
6.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.2K
Mismatch Repair
7.0K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.0K
Mismatch Repair
44.9K
Overview
44.9K


